UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 159

Sortiert nach

Mechanism of action of mRNA-based vaccines

Expert review of vaccines, 2017-09, Vol.16 (9), p.871-881

2017

Volltextzugriff (PDF)

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

PloS one, 2016-08, Vol.11 (8), p.e0161193-e0161193

2016

Volltextzugriff (PDF)

RNA: The new revolution in nucleic acid vaccines

Seminars in immunology, 2013-04, Vol.25 (2), p.152-159

2013

Volltextzugriff (PDF)

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

The Journal of immunology (1950), 2017-05, Vol.198 (10), p.4012-4024

2017

Volltextzugriff (PDF)

Nonviral delivery of self-amplifying RNA vaccines

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (36), p.14604-14609

2012

Volltextzugriff (PDF)

Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

Nature communications, 2018-07, Vol.9 (1), p.2714-13, Article 2714

2018

Volltextzugriff (PDF)

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Molecular therapy, 2014-12, Vol.22 (12), p.2118-2129

2014

Volltextzugriff (PDF)

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Molecular therapy, 2019-04, Vol.27 (4), p.757-772

2019

Volltextzugriff (PDF)

Cross-protection induced by highly conserved human B, CD4 + , and CD8 + T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

Frontiers in immunology, 2024, Vol.15, p.1328905-1328905

2024

Volltextzugriff (PDF)

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 + and CD8 + memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients

Frontiers in immunology, 2024-03, Vol.15, p.1343716-1343716

2024

Volltextzugriff (PDF)

Stopping pandemics before they start: Lessons learned from SARS-CoV-2

Science (American Association for the Advancement of Science), 2022-03, Vol.375 (6585), p.1133-1139

2022

Volltextzugriff (PDF)

Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA

Molecular Frontiers journal, 2021-06, Vol.5 (1n02), p.38-57

2021

Volltextzugriff (PDF)

Recent innovations in mRNA vaccines

Current opinion in immunology, 2016-08, Vol.41, p.18-22

2016

Volltextzugriff (PDF)

DNA VACCINES

Annual review of immunology, 1997-01, Vol.15 (1), p.617-648

1997

Volltextzugriff (PDF)

Antibody-guided structure-based vaccines

Seminars in immunology, 2020-08, Vol.50, p.101428-101428, Article 101428

2020

Volltextzugriff (PDF)

RNA-based vaccines

Vaccine, 2012-06, Vol.30 (30), p.4414-4418

2012

Volltextzugriff (PDF)

Vaccine adjuvants: mode of action

Frontiers in immunology, 2013-01, Vol.4, p.214-214

2013

Volltextzugriff (PDF)

Vaccine manufacturing: challenges and solutions

Nature biotechnology, 2006-11, Vol.24 (11), p.1377-1383

2006

Volltextzugriff (PDF)

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

Expert opinion on drug delivery, 2014-06, Vol.11 (6), p.885-899

2014

Volltextzugriff (PDF)

CpG Oligodeoxynucleotides Adsorbed onto Polylactide-Co-Glycolide Microparticles Improve the Immunogenicity and Protective Activity of the Licensed Anthrax Vaccine

Infection and Immunity, 2005-02, Vol.73 (2), p.828-833

2005

Volltextzugriff (PDF)

Vaccines on demand, part II: future reality

Expert opinion on drug discovery, 2023-02, Vol.18 (2), p.119-127

2023

Volltextzugriff (PDF)

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Journal of Virology, 2003-10, Vol.77 (20), p.11244-11259

2003

Volltextzugriff (PDF)

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

Journal of virology, 2016-01, Vol.90 (1), p.332-344

2016

Volltextzugriff (PDF)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

Vaccines (Basel), 2013-08, Vol.1 (3), p.367-383

2013

Volltextzugriff (PDF)

Targeting the innate immune response with improved vaccine adjuvants

Nature medicine, 2005-04, Vol.11 (4 Suppl), p.S63-S68

2005

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(159)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(113)
Animals
(101)
Humans
(75)
Mice
(54)
Immunology
(52)
Biological And Medical Sciences
(44)
Vaccines, Dna - Immunology
(42)
Fundamental And Applied Biological Sciences. Psychology
(35)
Female
(32)
Medicine, Research & Experimental
(31)
Research & Experimental Medicine
(31)
Virology
(31)
Microbiology
(30)
Mice, Inbred Balb C
(27)
Vaccines, Dna - Administration & Dosage
(27)
Vaccines
(26)
T-Lymphocytes, Cytotoxic - Immunology
(22)
Infectious Diseases
(21)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mechanism of action of mRNA-based vaccines

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

RNA: The new revolution in nucleic acid vaccines

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Nonviral delivery of self-amplifying RNA vaccines

Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Cross-protection induced by highly conserved human B, CD4 + , and CD8 + T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 + and CD8 + memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients

Stopping pandemics before they start: Lessons learned from SARS-CoV-2

Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA

Recent innovations in mRNA vaccines

DNA VACCINES

Antibody-guided structure-based vaccines

RNA-based vaccines

Vaccine adjuvants: mode of action

Vaccine manufacturing: challenges and solutions

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

CpG Oligodeoxynucleotides Adsorbed onto Polylactide-Co-Glycolide Microparticles Improve the Immunogenicity and Protective Activity of the Licensed Anthrax Vaccine

Vaccines on demand, part II: future reality

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

Targeting the innate immune response with improved vaccine adjuvants

Suchergebnisse filtern